Simplex Trading, LLC Vericel Corp Transaction History

Simplex Trading, LLC

$195 Billion
Q3 2025

A detailed history of Simplex Trading, LLC transactions in Vericel Corp stock. As of the latest transaction made, Simplex Trading, LLC holds 46 shares of VCEL stock, worth $1,833. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$1,833

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$29.84 - $41.74 $1,372 - $1,920	46 New	46 $1,000
Q4 2023 Feb 02, 2024	SELL	$30.85 - $37.09 $2,252 - $2,707	-73 Reduced 8.62%	774 $27,000
Q3 2023 Nov 01, 2023	BUY	$31.69 - $39.25 $26,841 - $33,244	847 New	847 $28,000
Q3 2022 Nov 04, 2022	BUY	$22.62 - $32.54 $6,107 - $8,785	270 New	270 $6,000
Q2 2022 Aug 03, 2022	SELL	$22.88 - $39.45 $6,520 - $11,243	-285 Closed	0 $0

Q1 2022 May 02, 2022	SELL	$31.69 - $43.29 $146,724 - $200,432	-4,630 Reduced 94.2%	285 $10,000
Q4 2021 Feb 23, 2022	BUY	$35.2 - $52.6 $127,036 - $189,833	3,609 Added 276.34%	4,915 $193,000
Q3 2021 Oct 28, 2021	BUY	$46.35 - $59.75 $9,270 - $11,950	200 Added 18.08%	1,306 $68,000
Q2 2021 Aug 12, 2021	BUY	$47.2 - $67.81 $52,203 - $74,997	1,106 New	1,106 $58,000
Q1 2021 Apr 26, 2021	SELL	$30.93 - $59.48 $31,579 - $60,729	-1,021 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$18.53 - $31.5 $18,919 - $32,161	1,021 New	1,021 $31,000
Q3 2020 Oct 14, 2020	SELL	$14.68 - $19.12 $27,246 - $35,486	-1,856 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$8.5 - $15.82 $38,649 - $71,933	-4,547 Reduced 71.01%	1,856 $25,000
Q1 2020 Apr 29, 2020	BUY	$7.25 - $19.22 $46,421 - $123,065	6,403 New	6,403 $58,000
Q4 2019 Feb 05, 2020	SELL	$13.77 - $19.2 $13,301 - $18,547	-966 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$14.93 - $19.83 $112,661 - $149,637	-7,546 Reduced 88.65%	966 $14,000
Q2 2019 Jul 26, 2019	BUY	$15.01 - $18.89 $52,474 - $66,039	3,496 Added 69.7%	8,512 $160,000
Q1 2019 Apr 18, 2019	SELL	$16.23 - $20.29 $96,779 - $120,989	-5,963 Reduced 54.31%	5,016 $0
Q4 2018 Jan 16, 2019	BUY	$10.77 - $18.44 $118,243 - $202,452	10,979 New	10,979 $191,000
Q3 2018 Oct 23, 2018	SELL	$9.1 - $14.8 $27,118 - $44,104	-2,980 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$9.6 - $14.6 $8,793 - $13,373	916 Added 44.38%	2,980 $28,000
Q1 2018 Apr 26, 2018	BUY	$5.7 - $12.3 $8,054 - $17,379	1,413 Added 217.05%	2,064 $20,000
Q4 2017 Jan 10, 2018	SELL	$3.65 - $5.98 $14,154 - $23,190	-3,878 Reduced 85.63%	651 $3,000
Q3 2017 Oct 25, 2017	BUY	$3.0 - $6.0 $13,587 - $27,174	4,529	4,529 $27,000

Others Institutions Holding VCEL

# of Institutions

275

Shares Held

52.6M

Call Options Held

36.6K

Put Options Held

9.1K

Black Rock Inc. New York, NY

8.06M
Shares

$321 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.52M
Shares

$140 Million
0.0% of portfolio
State Street Corp Boston, MA

2.81M
Shares

$112 Million
0.0% of portfolio
William Blair Investment Management, LLC Chicago, IL

2.21M
Shares

$88.1 Million
0.19% of portfolio
Conestoga Capital Advisors, LLC

2.18M
Shares

$86.7 Million
1.1% of portfolio

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.88B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account